Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. MU
3. HTZ
4. FDX
5. CBRS
6. USO
7. SPY
8. KBH
9. LAES
10. HON

Go back to Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma

Delcath Systems (DCTH) Tops Q1 EPS by 11c

May 4, 2016 9:12 AM EDT

Delcath Systems (NASDAQ: DCTH) reported Q1 EPS of ($0.08), $0.11 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $370 thousand, versus $444 thousand reported last year.

For earnings history and earnings-related data on Delcath Systems (DCTH) click here.

... More